Szymon Kowalski

Mr. Szymon Kowalski

Wroclaw Medical University, Wroclaw, Poland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2023 in Membranes
Verified
Journal Article
Open access
PDF file
JKJulia Karska
Julia Karska
SKSzymon Kowalski
Szymon Kowalski
JSJolanta Saczko
Jolanta Saczko
MMMihaela Moisescu
Mihaela Moisescu
Julita KulbackaJulita Kulbacka
Julita Kulbacka
Mechanical forces are an inherent element in the world around us. The effects of their action can be observed both on the macro and molecular levels. They can also play a prominent role in the tissues and cells of animals due to the presence of mechanosensitive ion channels (MIChs) such as the Piezo and TRP families. They are essential in many physiological processes in the human body. However, their role in pathology has also been observed. Recent discoveries have highlighted the relationship between these channels and the development of malignant tumors. Multiple studies have shown that MIChs mediate the proliferation, migration, and invasion of various cancer cells via various mechanisms. This could show MIChs as new potential biomarkers in cancer detection and prognosis and interesting therapeutic targets in modern oncology. Our paper is a review of the latest literature on the role of the Piezo1 and TRP families in the molecular mechanisms of carcinogenesis in different types of cancer.

4 February 2024 in Molecules
Verified
Journal Article
Open access
PDF file
SKSzymon Kowalski
Szymon Kowalski
JKJulia Karska
Julia Karska
MTMaciej Tota
Maciej Tota
KSKatarzyna Skinderowicz
Katarzyna Skinderowicz
Julita KulbackaJulita Kulbacka
Julita Kulbacka
MDMaŁgorzata Dra̧g-Zalesińska
MaŁgorzata Dra̧g-Zalesińska
The elevated occurrence of non-melanoma skin cancer (NMSC) and the adverse effects associated with available treatments adversely impact the quality of life in multiple dimensions. In connection with this, there is a necessity for alternative approaches characterized by increased tolerance and lower side effects. Natural compounds could be employed due to their safety profile and effectiveness for inflammatory and neoplastic skin diseases. These anti-cancer drugs are often derived from natural sources such as marine, zoonotic, and botanical origins. Natural compounds should exhibit anti-carcinogenic actions through various pathways, influencing apoptosis potentiation, cell proliferation inhibition, and metastasis suppression. This review provides an overview of natural compounds used in cancer chemotherapies, chemoprevention, and promotion of skin regeneration, including polyphenolic compounds, flavonoids, vitamins, alkaloids, terpenoids, isothiocyanates, cannabinoids, carotenoids, and ceramides.

24 August 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MJMichał Jarocki
Michał Jarocki
JKJulia Karska
Julia Karska
SKSzymon Kowalski
Szymon Kowalski
PKPaweł Kiełb
Paweł Kiełb
ŁNŁukasz Nowak
Łukasz Nowak
Bartosz MałkiewiczBartosz Małkiewicz
Bartosz Małkiewicz
Nowadays, molecular and immunological research is essential for the better understanding of tumor cells pathophysiology. The increasing number of neoplasms has been taken under ‘the molecular magnifying glass’ and, therefore, it is possible to discover complex relationships between the cytophysiology and immune system action. An example could be renal cell carcinoma (RCC) which has deep interactions with immune mediators such as Interleukin 17 (IL-17)—an inflammatory cytokine reacting to tissue damage and external pathogens. RCC is one of the most fatal urological cancers because of its often late diagnosis and poor susceptibility to therapies. IL-17 and its relationship with tumors is extremely complex and constitutes a recent topic for numerous studies. What is worth highlighting is IL-17’s dual character in cancer development—it could be pro- as well as anti-tumorigenic. The aim of this review is to summarize the newest data considering multiple connections between IL-17 and RCC.

21 June 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
MJMichał Jarocki
Michał Jarocki
JKJulia Karska
Julia Karska
SKSzymon Kowalski
Szymon Kowalski
PKPaweł Kiełb
Paweł Kiełb
ŁNŁukasz Nowak
Łukasz Nowak
Bartosz MałkiewiczBartosz Małkiewicz
Bartosz Małkiewicz
Nowadays molecular and immunological research is essential for the better understanding of tumor cells pathophysiology. The increasing number of neoplasms is taken under ‘the molecular magnifying glass’ therefore it is possible to discover complex relationships between cytophysiology and immune system action. An example could be renal cell carcinoma (RCC) which has deep interactions with immune mediators such as Interleukin 17 (IL-17) - an inflammatory cytokine reacting to tissue damage and external pathogens. RCC is one of the most fatal urological cancer because of its often late diagnosis and poor susceptibility to therapies. IL-17 and its relation with tumors is extremely complex and constitute a recent topic for numerous research. What is worth highlighting is IL-17 dual character in cancer development - it could be pro- as well as antitumorigenic. The aim of this review is to summarize the newest data considering multiple connections between IL-17 and RCC.